<DOC>
	<DOC>NCT02122393</DOC>
	<brief_summary>Th purpose of this study is to determine whether dual psychological and pharmacological treatment is superior to either mono-therapy alone in the treatment of postnatal depression.</brief_summary>
	<brief_title>A Randomised Trial of Sertraline, Cognitive Behaviour Therapy &amp; Combined Therapy for Postnatal Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression, Postpartum</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Women with an infant &gt; 2 months and &lt; 8 months of age Infant born after a fullterm pregnancy Infant born with no congenital abnormalities Diagnosis of depression with postnatal onset according to the Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSMIV). positive serum pregnancy test; concurrent psychiatric disorder (excepting comorbid anxiety); recent history of antidepressant usage (within the last month); history of major allergy or drug allergy; history of substance abuse; prior nonresponse to sertraline, or prior nonresponse to adequate trials of two selective serotonin reuptake inhibitors (SSRIs); predisposition to headache, migraine or nausea; tobacco habit in excess of 10 cigarettes per day; caffeine consumption in excess of 6 cups of coffee/tea or colaflavoured drinks per day; ongoing dental work; extreme levels of depression (psychotic); suicidal intent; participation in any medical trial within the previous three months;</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>